Dimensional Fund Advisors’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Dimensional Fund Advisors’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-23,227	Closed	-$191K	–	3575
2022 Q3	$191K	Sell	23,227 -1,800	-7%	-$13.8K	﹤0.01%	3248
2022 Q2	$164K	Hold	25,027	–	–	﹤0.01%	3273
2022 Q1	$140K	Buy	25,027 +200	+0.8%	+$824	﹤0.01%	3357
2021 Q4	$116K	Buy	24,827 +1,144	+5%	+$7.1K	﹤0.01%	3418
2021 Q3	$146K	Sell	23,683 -4,662	-16%	-$27.9K	﹤0.01%	3388
2021 Q2	$187K	Hold	28,345	–	–	﹤0.01%	3348
2021 Q1	$207K	Buy	28,345 +3,984	+16%	+$34.4K	﹤0.01%	3285
2020 Q4	$141K	Buy	+24,361	New	+$139K	﹤0.01%	3259
2014 Q4	–	Sell	-28,535	Closed	-$317K	–	3531
2014 Q3	$317K	Sell	28,535 -1,964	-6%	-$25K	﹤0.01%	3217
2014 Q2	$558K	Sell	30,499 -1,269	-4%	-$16.5K	﹤0.01%	3167
2014 Q1	$475K	Sell	31,768 -7,196	-18%	-$129K	﹤0.01%	3205
2013 Q4	$717K	Sell	38,964 -1,658	-4%	-$33.2K	﹤0.01%	3099
2013 Q3	$841K	Buy	40,622 +9,134	+29%	+$209K	﹤0.01%	3073
2013 Q2	$787K	Buy	+31,488	New	+$1.35M	﹤0.01%	3072

Other funds holding AVEO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Dimensional Fund Advisors's AVEO Position: Q4 2022 in Review

Dimensional Fund Advisors sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2022, closing a stake of 23,227 shares — an estimated $191K sold.

Dimensional Fund Advisors first reported a position in AVEO in Q2 2013 and held it in 14 quarters. The position peaked at $841K in Q3 2013. 110 funds tracked by Wall St. Rank hold AVEO as of Q4 2022.

Dimensional Fund Advisors reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
Dimensional Fund Advisors sold 23,227 AVEO Pharmaceuticals, Inc. shares in Q4 2022, an estimated $191K.
Dimensional Fund Advisors first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 14 quarters.
Dimensional Fund Advisors's AVEO Pharmaceuticals, Inc. position peaked at $841K in Q3 2013.
110 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2022.

Based on Dimensional Fund Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.